Microbot Medical Inc. (NASDAQ: MBOT) is a commercial stage medical device company focused on transforming endovascular procedures through advanced robotic technology. Microbot’s LIBERTY® Endovascular Robotic System is the world’s first FDA cleared single-use, remotely operated robotic solution designed for precision, efficiency and safety. Backed by a strong intellectual property portfolio and a commitment to innovation, Microbot is driving the future of endovascular care.
Looking for a particular Microbot Medical employee's phone or email?
The Microbot Medical annual revenue was $5.8 million in 2026.
Harel Gadot is the CEO, President and Chairman of Microbot Medical.
29 people are employed at Microbot Medical.
Microbot Medical is based in Hingham, Massachusetts.
The NAICS codes for Microbot Medical are [339, 33].
The SIC codes for Microbot Medical are [384, 38].